The role of 5-HT1A autoreceptors and alpha1-adrenoceptors in the modulation of 5-HT release--III. Clozapine and the novel putative antipsychotic S 16924. (Q47775228)

From Wikidata

Jump to navigation Jump to search

scientific article published in January 1998

Language	Label	Description	Also known as
English	The role of 5-HT1A autoreceptors and alpha1-adrenoceptors in the modulation of 5-HT release--III. Clozapine and the novel putative antipsychotic S 16924.	scientific article published in January 1998

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9681933

The role of 5-HT1A autoreceptors and alpha1-adrenoceptors in the modulation of 5-HT release--III. Clozapine and the novel putative antipsychotic S 16924. (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9681933

author name string

Bengtsson HJ

1

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9681933

Kullberg A

2

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9681933

Millan MJ

3

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9681933

Hjorth S

4

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9681933

publication date

1 January 1998

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9681933

number of pages

8

1 reference

based on heuristic

inferred from page(s)

Neuropharmacology

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9681933

37

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9681933

3

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9681933

349-356

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9681933

Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900017-3

7 January 2021

Noradrenergic innervation of serotonergic neurons in the dorsal raphe: Demonstration by electron microscopic autoradiography

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900017-3

7 January 2021

5-HT1A receptors are not involved in clozapine's lack of cataleptogenic potential

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900017-3

7 January 2021

Effect of metergoline, fenfluramine, and 8-OHDPAT on catalepsy induced by haloperidol or morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900017-3

7 January 2021

New Insights into the Biology of Schizophrenia through the Mechanism of Action of Clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900017-3

7 January 2021

Clozapine decreases serotonin extracellular levels in the nucleus accumbens by a dopamine receptor-independent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900017-3

7 January 2021

Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900017-3

7 January 2021

A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900017-3

7 January 2021

Serotonin 5-HT1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo: a microdialysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900017-3

7 January 2021

Studies on the role of 5-HT1A autoreceptors and alpha 1-adrenoceptors in the inhibition of 5-HT release--I. BMY7378 and prazosin

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900017-3

7 January 2021

The 5-HT 1A receptor agonist, 8-OH-DPAT, preferentially activates cell body 5-HT autoreceptors in rat brain in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900017-3

7 January 2021

Catalepsy as a rodent model for detecting antipsychotic drugs with extrapyramidal side effect liability

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900017-3

7 January 2021

Selectivity of the imidazoline alpha-adrenoceptor agonists (oxymetazoline and cirazoline) for human cloned alpha 1-adrenoceptor subtypes

2 references

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900017-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900017-3

7 January 2021

based on heuristic

inferred from DOI database lookup

8-Hydroxy-2-(di-n-propylamino) tetralin, a selective serotonin1A receptor agonist, blocks haloperidol-induced catalepsy by an action on raphe nuclei medianus and dorsalis

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900017-3

7 January 2021

Clozapine inhibits serotoninergic transmission by an action at alpha 1-adrenoceptors not at 5-HT1A receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900017-3

7 January 2021

8-OH-DPAT, a 5-HT1A agonist and ritanserin, a 5-HT2A/C antagonist, reverse haloperidol-induced catalepsy in rats independently of striatal dopamine release

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900017-3

7 January 2021

Clozapine is a partial agonist at cloned, human serotonin 5-HT1A receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900017-3

7 January 2021

Electrophysiological responses of serotoninergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900017-3

7 January 2021

Antipsychotic-like profile of combined treatment with raclopride and 8-OH-DPAT in the rat: enhancement of antipsychotic-like effects without catalepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900017-3

7 January 2021

Stimulation of median, but not dorsal, raphe 5-HT1A autoreceptors by the local application of 8-OH-DPAT reverses raclopride-induced catalepsy in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2898%2900017-3

7 January 2021

Identifiers

10.1016/S0028-3908(98)00017-3

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9681933

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9681933

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47775228&oldid=1786185493"